Literature DB >> 23026672

ISTH guidelines on lupus anticoagulant testing.

V Pengo1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23026672     DOI： 10.1016/j.thromres.2012.08.283

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  9 in total

1.  Perioperative management of patients with antiphospholipid syndrome: a single-center experience.

Authors:  Yemil Atisha-Fregoso; Eric Espejo-Poox; Eduardo Carrillo-Maravilla; Alma Lilia Pulido-Ramírez; Diego Lugo Baruqui; Gabriela Hernández-Molina; Antonio R Cabral
Journal:  Rheumatol Int       Date:  2017-05-04       Impact factor: 2.631

2.  Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Authors:  Ömer Uludağ; Murat Bektaş; Erhan Çene; Murat Sezer; Yasemin Şahinkaya; Ahmet Gül; Murat Inanç; Lale Öcal; Bahar Artim-Esen
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

3.  Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases.

Authors:  Cecilia Nalli; Valentina Somma; Laura Andreoli; Thomas Büttner; Peter Schierack; Michael Mahler; Dirk Roggenbuck; Angela Tincani
Journal:  Auto Immun Highlights       Date:  2018-05-29

4.  High Incidence of Antiphospholipid Antibodies in Newly Diagnosed Patients With Lymphoma and a Proposed aPL Predictive Score.

Authors:  Smith Kungwankiattichai; Yupa Nakkinkun; Weerapat Owattanapanich; Theera Ruchutrakool
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats.

Authors:  Paolo Durigutto; Claudia Grossi; Maria Orietta Borghi; Paolo Macor; Francesca Pregnolato; Elena Raschi; Michael P Myers; Philip G de Groot; Pier Luigi Meroni; Francesco Tedesco
Journal:  Haematologica       Date:  2018-11-15       Impact factor: 9.941

6.  Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.

Authors:  Paola Adele Lonati; Mariangela Scavone; Maria Gerosa; Maria Orietta Borghi; Francesca Pregnolato; Daniele Curreli; Gianmarco Podda; Eti Alessandra Femia; Wilma Barcellini; Marco Cattaneo; Francesco Tedesco; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 7.  COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?

Authors:  Georges El Hasbani; Ali T Taher; Ali Jawad; Imad Uthman
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2020-12-03

8.  Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Authors:  Dirk Roggenbuck; Maria Orietta Borghi; Valentina Somma; Thomas Büttner; Peter Schierack; Katja Hanack; Claudia Grossi; Caterina Bodio; Paolo Macor; Philipp von Landenberg; Francesco Boccellato; Michael Mahler; Pier Luigi Meroni
Journal:  Arthritis Res Ther       Date:  2016-05-21       Impact factor: 5.156

9.  Serum Metabolic Profiles Based on Nuclear Magnetic Resonance Spectroscopy among Patients with Deep Vein Thrombosis and Healthy Controls.

Authors:  Melissa Quintero Escobar; Ljubica Tasic; Tassia Brena Barroso Carneiro da Costa; Danijela Stanisic; Silmara Montalvão; Stephany Huber; Joyce Maria Annichino-Bizzacchi
Journal:  Metabolites       Date:  2021-12-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.